99.5 %Near-universal resistance (99.5%) was observed for itraconazole among Candida isolates.
Nigeriaoral candidiasis · VIH/sidapublished 2026BMC infectious diseasesPubMeddocument of 11 observations
Gold tier: mechanically validated evidence, with its primary source.
1,729 evidence items · page 52 / 70
99.5 %Near-universal resistance (99.5%) was observed for itraconazole among Candida isolates.
Nigeriaoral candidiasis · VIH/sidapublished 2026BMC infectious diseasesPubMeddocument of 11 observations
16 %At baseline, the proportion of type B tympanogram was 16.0% in the right ear and 15.3% in the left ear among 150 HIV-positive patients.
NigeriaVIH/sidapublished 2023Nigerian journal of clinical practicePubMeddocument of 6 observations
35.9 %The CYP2B6:516 G/G genotype frequency was 35.9% among participants with genotype results.
NigeriaVIH/sidapublished 2020Nigerian journal of clinical practicePubMeddocument of 8 observations
0 %The prevalence of the HLA-B*57:01 allele among 1458 successfully typed HIV-positive adults in Nigeria was 0%.
NigeriaVIH/sidaobserved April 2016 to April 2017published 2019The Nigerian postgraduate medical journalPubMeddocument of 6 observations
Hemoglobin genotype distribution among HIV-1 patients was comparable to that in the general population of Nigeria.
NigeriaVIH/sidapublished 2022The open AIDS journaleurope_pmcdocument of 3 observations
0.1 daysParticipants in the point-of-care arm received viral load results significantly faster than those in the standard-of-care arm, with a median of 0.1 days (interquartile range 0.1–0.2) versus 143.1 days (interquartile range 56.0–177.1), respectively.
NigeriaVIH/sidaobserved April 2018 to October 2019published 2023Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument of 2 observations
26 %Nigeria's widespread mixed epidemiology HIV program has achieved a 26% reduction in new HIV infections since 2010.
NigeriaVIH/sidaobserved since 2010published 2023Sexual healthPubMed
27.7 %Only 27.7% of respondents in the control group increased their HIV/AIDS knowledge post-test.
NigeriaVIH/sidapublished 2024BMC public healthPubMeddocument of 5 observations
60 daysAmong those not retained, mean days to be lost-to-follow up was 60 days.
NigeriaVIH/sidapublished 2025BMC public healthPubMeddocument of 8 observations
5.07 %The rate of new HIV infection among blood donors in this study was 5.07%.
NigeriaVIH/sidapublished 2021Journal of medical virologyPubMeddocument of 11 observations
1.67 risk_ratioHaving viral load < 50 copies/mL was associated with HIV status disclosure to male sexual partners (RR 1.67 [95% CI 1.24–2.25]).
NigeriaVIH/sidapublished 2020BMC public healthPubMeddocument of 6 observations
4.14 AORThe adjusted odds ratio for repeat HIV testing among HIV-negative pregnant women at term referred by TBAs in cluster 1 was 4.14 (95% CI [2.82–5.99]).
NigeriaVIH/sidapublished 2024BMC pregnancy and childbirthPubMeddocument of 8 observations
2.525 odds_ratioHIV-positive children were more likely to have intestinal helminthiasis than HIV-negative children, with an odds ratio of 2.525.
Nigeriaintestinal helminthiasis · VIH/sidapublished 2024Nigerian journal of clinical practicePubMeddocument of 4 observations
50 casesFifty (98.0%) low risk infants had HIV DNA PCR testing between 6–8 weeks.
NigeriaVIH/sidapublished 2025West African journal of medicinePubMeddocument of 8 observations
7.1 %The rate of mother-to-child transmission of HIV infection was 7.1% as previously reported by the center.
NigeriaVIH/sidapublished 2023Japanese journal of infectious diseasesPubMeddocument of 5 observations
Female sex workers in Nigeria carry a disproportionate Human Immunodeficiency Virus (HIV) burden.
NigeriaVIH/sidapublished 2026BMC public healthPubMeddocument of 3 observations
438 clients438 out of the 562 (78%) returnee PLHIV gave consent and participated in the study.
NigeriaVIH/sidapublished 2019AIDS research and therapyPubMeddocument of 14 observations
121 individualsThe study included 121 consecutive children with HIV/AIDS on HAART.
NigeriaVIH/sidapublished 2025African health sciencesPubMeddocument of 7 observations
18.8 %Three (18.8%) of 16 participants were HIV-1 positive.
NigeriaVIH/sidaobserved 2017-2018published 2022International journal of STD & AIDSPubMeddocument of 8 observations
22.7 %The prevalence of partial disclosure of HIV status to children in Abuja, Nigeria was 22.7%.
NigeriaVIH/sidaobserved 2016published 2020Nigerian journal of clinical practicePubMeddocument of 5 observations
40 %By increasing the annual number of HIV counseling and testing (HCT) services by 100 percent, the unit cost decreases by 40 percent.
NigeriaVIH/sidapublished 2023PloS onePubMeddocument of 10 observations
44 %22 (44%) of the 50 men were classified as people living with HIV.
NigeriaVIH/sidaHAL · Unilimdocument of 102 observations
There was a sharp decline in performance in adherence assessment to antiretroviral drugs between 2010 and 2012, with p < 0.01.
NigeriaVIH/sidaobserved 2010 to 2012published 2019AIDS research and therapyPubMeddocument of 5 observations
7,361 individualsThe latent class analysis identified four distinct subgroups of adolescents and young adults based on patterns of barriers to HIV testing: 'low-risk perception' (n = 7,361; 39.5%), 'consent and proximity' (n = 5,163; 27.74%), 'testing site' (n = 4,996; 26.84%), and 'cost and logistics' (n = 1,092; 5.87%).
NigeriaVIH/sidaobserved 2018published 2024PloS onePubMeddocument of 15 observations
4.22 aORFemale sex workers residing in the North East geopolitical zone of Nigeria had higher odds of prenatal HIV testing compared to those in the South South zone (adjusted odds ratio = 4.22).
NigeriaVIH/sidapublished 2024International journal of STD & AIDSPubMeddocument of 12 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.